Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Kidney Disease Drugs market report explains the definition, types, applications, major countries, and major players of the Kidney Disease Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Keryx Biopharmaceuticals
Pfizer
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Sanofi
Amgen
zhejiang Shengbokang Pharmaceutical
Tianjin Tongrentang Group
Datong Liqun Pharmaceutical
Teva Pharmaceutical Industries
AstraZeneca
Changxing Pharmaceutical
Kissei Pharmaceutical
Hebei Ruisen Pharmaceutical
Roche
GlaxoSmithKline
AbbVie
By Type:
Tablets
Capsule
Other
By End-User:
Chronic Glomerulonephritis
Nephrotic Syndrome
Chronic Renal Failure
Kidney Stones
Renal Cyst (polycystic Kidney)
Diabetic Nephropathy
Hypertensive Nephropathy
Purpura Nephritis
Lupus Nephritis
Pediatric Kidney Disease
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Kidney Disease Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Kidney Disease Drugs Outlook to 2028- Original Forecasts
-
2.2 Kidney Disease Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Kidney Disease Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Kidney Disease Drugs Market- Recent Developments
-
6.1 Kidney Disease Drugs Market News and Developments
-
6.2 Kidney Disease Drugs Market Deals Landscape
7 Kidney Disease Drugs Raw Materials and Cost Structure Analysis
-
7.1 Kidney Disease Drugs Key Raw Materials
-
7.2 Kidney Disease Drugs Price Trend of Key Raw Materials
-
7.3 Kidney Disease Drugs Key Suppliers of Raw Materials
-
7.4 Kidney Disease Drugs Market Concentration Rate of Raw Materials
-
7.5 Kidney Disease Drugs Cost Structure Analysis
-
7.5.1 Kidney Disease Drugs Raw Materials Analysis
-
7.5.2 Kidney Disease Drugs Labor Cost Analysis
-
7.5.3 Kidney Disease Drugs Manufacturing Expenses Analysis
8 Global Kidney Disease Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Kidney Disease Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Kidney Disease Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Kidney Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Glomerulonephritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Nephrotic Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Chronic Renal Failure Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Kidney Stones Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Renal Cyst (polycystic Kidney) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Hypertensive Nephropathy Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Purpura Nephritis Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Lupus Nephritis Consumption and Growth Rate (2017-2022)
-
9.2.10 Global Pediatric Kidney Disease Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Kidney Disease Drugs Market Analysis and Outlook till 2022
-
10.1 Global Kidney Disease Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Kidney Disease Drugs Consumption (2017-2022)
-
10.2.2 Canada Kidney Disease Drugs Consumption (2017-2022)
-
10.2.3 Mexico Kidney Disease Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Kidney Disease Drugs Consumption (2017-2022)
-
10.3.2 UK Kidney Disease Drugs Consumption (2017-2022)
-
10.3.3 Spain Kidney Disease Drugs Consumption (2017-2022)
-
10.3.4 Belgium Kidney Disease Drugs Consumption (2017-2022)
-
10.3.5 France Kidney Disease Drugs Consumption (2017-2022)
-
10.3.6 Italy Kidney Disease Drugs Consumption (2017-2022)
-
10.3.7 Denmark Kidney Disease Drugs Consumption (2017-2022)
-
10.3.8 Finland Kidney Disease Drugs Consumption (2017-2022)
-
10.3.9 Norway Kidney Disease Drugs Consumption (2017-2022)
-
10.3.10 Sweden Kidney Disease Drugs Consumption (2017-2022)
-
10.3.11 Poland Kidney Disease Drugs Consumption (2017-2022)
-
10.3.12 Russia Kidney Disease Drugs Consumption (2017-2022)
-
10.3.13 Turkey Kidney Disease Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Kidney Disease Drugs Consumption (2017-2022)
-
10.4.2 Japan Kidney Disease Drugs Consumption (2017-2022)
-
10.4.3 India Kidney Disease Drugs Consumption (2017-2022)
-
10.4.4 South Korea Kidney Disease Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Kidney Disease Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Kidney Disease Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Kidney Disease Drugs Consumption (2017-2022)
-
10.4.8 Thailand Kidney Disease Drugs Consumption (2017-2022)
-
10.4.9 Singapore Kidney Disease Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Kidney Disease Drugs Consumption (2017-2022)
-
10.4.11 Philippines Kidney Disease Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Kidney Disease Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Kidney Disease Drugs Consumption (2017-2022)
-
10.5.2 Colombia Kidney Disease Drugs Consumption (2017-2022)
-
10.5.3 Chile Kidney Disease Drugs Consumption (2017-2022)
-
10.5.4 Argentina Kidney Disease Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Kidney Disease Drugs Consumption (2017-2022)
-
10.5.6 Peru Kidney Disease Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Kidney Disease Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Kidney Disease Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Kidney Disease Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Kidney Disease Drugs Consumption (2017-2022)
-
10.6.3 Oman Kidney Disease Drugs Consumption (2017-2022)
-
10.6.4 Qatar Kidney Disease Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Kidney Disease Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Kidney Disease Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Kidney Disease Drugs Consumption (2017-2022)
-
10.7.2 South Africa Kidney Disease Drugs Consumption (2017-2022)
-
10.7.3 Egypt Kidney Disease Drugs Consumption (2017-2022)
-
10.7.4 Algeria Kidney Disease Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Kidney Disease Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Kidney Disease Drugs Consumption (2017-2022)
11 Global Kidney Disease Drugs Competitive Analysis
-
11.1 Keryx Biopharmaceuticals
-
11.1.1 Keryx Biopharmaceuticals Company Details
-
11.1.2 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Keryx Biopharmaceuticals Kidney Disease Drugs Main Business and Markets Served
-
11.1.4 Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Kidney Disease Drugs Main Business and Markets Served
-
11.2.4 Pfizer Kidney Disease Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
-
11.3.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Details
-
11.3.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
11.3.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sanofi
-
11.4.1 Sanofi Company Details
-
11.4.2 Sanofi Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sanofi Kidney Disease Drugs Main Business and Markets Served
-
11.4.4 Sanofi Kidney Disease Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Amgen
-
11.5.1 Amgen Company Details
-
11.5.2 Amgen Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Amgen Kidney Disease Drugs Main Business and Markets Served
-
11.5.4 Amgen Kidney Disease Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 zhejiang Shengbokang Pharmaceutical
-
11.6.1 zhejiang Shengbokang Pharmaceutical Company Details
-
11.6.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
11.6.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Tianjin Tongrentang Group
-
11.7.1 Tianjin Tongrentang Group Company Details
-
11.7.2 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Tianjin Tongrentang Group Kidney Disease Drugs Main Business and Markets Served
-
11.7.4 Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Datong Liqun Pharmaceutical
-
11.8.1 Datong Liqun Pharmaceutical Company Details
-
11.8.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
11.8.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Teva Pharmaceutical Industries
-
11.9.1 Teva Pharmaceutical Industries Company Details
-
11.9.2 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Teva Pharmaceutical Industries Kidney Disease Drugs Main Business and Markets Served
-
11.9.4 Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 AstraZeneca
-
11.10.1 AstraZeneca Company Details
-
11.10.2 AstraZeneca Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 AstraZeneca Kidney Disease Drugs Main Business and Markets Served
-
11.10.4 AstraZeneca Kidney Disease Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Changxing Pharmaceutical
-
11.11.1 Changxing Pharmaceutical Company Details
-
11.11.2 Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Changxing Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
11.11.4 Changxing Pharmaceutical Kidney Disease Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Kissei Pharmaceutical
-
11.12.1 Kissei Pharmaceutical Company Details
-
11.12.2 Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Kissei Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
11.12.4 Kissei Pharmaceutical Kidney Disease Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Hebei Ruisen Pharmaceutical
-
11.13.1 Hebei Ruisen Pharmaceutical Company Details
-
11.13.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
11.13.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Roche
-
11.14.1 Roche Company Details
-
11.14.2 Roche Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Roche Kidney Disease Drugs Main Business and Markets Served
-
11.14.4 Roche Kidney Disease Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 GlaxoSmithKline
-
11.15.1 GlaxoSmithKline Company Details
-
11.15.2 GlaxoSmithKline Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 GlaxoSmithKline Kidney Disease Drugs Main Business and Markets Served
-
11.15.4 GlaxoSmithKline Kidney Disease Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 AbbVie
-
11.16.1 AbbVie Company Details
-
11.16.2 AbbVie Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 AbbVie Kidney Disease Drugs Main Business and Markets Served
-
11.16.4 AbbVie Kidney Disease Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Kidney Disease Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Kidney Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Kidney Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Chronic Glomerulonephritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Nephrotic Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Chronic Renal Failure Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Kidney Stones Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Renal Cyst (polycystic Kidney) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Hypertensive Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.8 Global Purpura Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.9 Global Lupus Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.10 Global Pediatric Kidney Disease Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Kidney Disease Drugs Market Analysis and Outlook to 2028
-
13.1 Global Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Kidney Disease Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Kidney Disease Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Kidney Disease Drugs
-
Figure of Kidney Disease Drugs Picture
-
Table Global Kidney Disease Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Kidney Disease Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Glomerulonephritis Consumption and Growth Rate (2017-2022)
-
Figure Global Nephrotic Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Renal Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Stones Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cyst (polycystic Kidney) Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Nephropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertensive Nephropathy Consumption and Growth Rate (2017-2022)
-
Figure Global Purpura Nephritis Consumption and Growth Rate (2017-2022)
-
Figure Global Lupus Nephritis Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Kidney Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Disease Drugs Consumption by Country (2017-2022)
-
Table North America Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure Germany Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure China Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure Brazil Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure Australia Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Keryx Biopharmaceuticals Company Details
-
Table Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Keryx Biopharmaceuticals Kidney Disease Drugs Main Business and Markets Served
-
Table Keryx Biopharmaceuticals Kidney Disease Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Disease Drugs Main Business and Markets Served
-
Table Pfizer Kidney Disease Drugs Product Portfolio
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Details
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Kidney Disease Drugs Main Business and Markets Served
-
Table Sanofi Kidney Disease Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Kidney Disease Drugs Main Business and Markets Served
-
Table Amgen Kidney Disease Drugs Product Portfolio
-
Table zhejiang Shengbokang Pharmaceutical Company Details
-
Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Portfolio
-
Table Tianjin Tongrentang Group Company Details
-
Table Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tianjin Tongrentang Group Kidney Disease Drugs Main Business and Markets Served
-
Table Tianjin Tongrentang Group Kidney Disease Drugs Product Portfolio
-
Table Datong Liqun Pharmaceutical Company Details
-
Table Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Datong Liqun Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
Table Datong Liqun Pharmaceutical Kidney Disease Drugs Product Portfolio
-
Table Teva Pharmaceutical Industries Company Details
-
Table Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Kidney Disease Drugs Main Business and Markets Served
-
Table Teva Pharmaceutical Industries Kidney Disease Drugs Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Kidney Disease Drugs Main Business and Markets Served
-
Table AstraZeneca Kidney Disease Drugs Product Portfolio
-
Table Changxing Pharmaceutical Company Details
-
Table Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changxing Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
Table Changxing Pharmaceutical Kidney Disease Drugs Product Portfolio
-
Table Kissei Pharmaceutical Company Details
-
Table Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kissei Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
Table Kissei Pharmaceutical Kidney Disease Drugs Product Portfolio
-
Table Hebei Ruisen Pharmaceutical Company Details
-
Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Main Business and Markets Served
-
Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Portfolio
-
Table Roche Company Details
-
Table Roche Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Kidney Disease Drugs Main Business and Markets Served
-
Table Roche Kidney Disease Drugs Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Kidney Disease Drugs Main Business and Markets Served
-
Table GlaxoSmithKline Kidney Disease Drugs Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Kidney Disease Drugs Main Business and Markets Served
-
Table AbbVie Kidney Disease Drugs Product Portfolio
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Glomerulonephritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nephrotic Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Renal Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Stones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cyst (polycystic Kidney) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetic Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertensive Nephropathy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Purpura Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lupus Nephritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Kidney Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
